Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.15 -0.09 (-7.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Tvardi Therapeutics (TVRD) recorded Return on Capital Employed [ROCE] of -216.70% in Q2 2026, down 119.86 percentage points from -96.84% a year earlier and down 50.23 percentage points from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Tvardi Therapeutics reported Return on Capital Employed [ROCE] of -118.39%, down 78.32 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -120.69 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -40.06% in FY2024 (+54.52 pp), -94.59% in FY2023 (-48.80 pp), -45.78% in FY2022 (-8.90 pp) and -36.89% in FY2021 (-39.19 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2014.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of -8.30 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 83.76 percentage points in Q3 2021, against a drop of 119.86 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -166.48% (Q1 2026), -109.15% (Q4 2025) and -98.74% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Tvardi Therapeutics 10.79 Mn 10.79 Mn - -216.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -216.70%
Mar 31, 2026 -166.48%
Dec 31, 2025 -109.15%
Sep 30, 2025 -98.74%
Jun 30, 2025 -96.84%
Mar 31, 2025 -78.09%
Dec 31, 2024 -162.10%
Sep 30, 2024 -144.83%
Jun 30, 2024 -145.93%
Mar 31, 2024 -132.98%
Dec 31, 2023 -127.89%
Sep 30, 2023 -117.86%
Jun 30, 2023 -97.27%
Mar 31, 2023 -57.77%
Dec 31, 2022 -50.19%
Sep 30, 2022 -46.78%
Jun 30, 2022 -32.85%
Mar 31, 2022 -43.02%
Dec 31, 2021 -40.78%
Sep 30, 2021 10.94%
API Access

Tvardi Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TVRD&period=max&api_key=YOUR_API_KEY